Bain Capital Public Equity Management Ii, LLC Astrazeneca PLC Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.08 Billion
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $14.9 Million - $17.1 Million	-314,988 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $15.3 Million - $18.3 Million	314,988 New	314,988 $15.7 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $23.4 Million - $26.9 Million	-440,287 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $19 Million - $24.4 Million	440,287 New	440,287 $23.3 Million

Others Institutions Holding AZN

# of Institutions

1,348

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$4.64 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.04 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$2.9 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.62 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.26 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account